Gyre Therapeutics Inc (GYRE)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current GYRE market cap is 732.25M. The company's latest EPS is USD 0.1289 and P/E is 60.59.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 27.17M | 25.23M | 25.49M | 27.87M | 22.06M |
| Operating Income | 8.07M | 3.26M | 4.23M | 663k | 2.27M |
| Net Income | 7.53M | 3.53M | 1.12M | -99k | 2.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 20.95M | 7.34M | 794k | 113.45M | 105.76M |
| Operating Income | -57.37M | -87.89M | -65.8M | -63.89M | 16.23M |
| Net Income | -56.24M | -87.93M | -8.24M | -92.93M | 12.09M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 122.01M | 120.93M | 125.24M | 125.41M | 129.79M |
| Total Liabilities | 33.24M | 27.58M | 26.77M | 27M | 25.49M |
| Total Equity | 88.77M | 93.35M | 98.47M | 98.4M | 104.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 94.85M | 55.66M | 28.44M | 116.54M | 125.41M |
| Total Liabilities | 18.78M | 14.57M | 16.82M | 38.07M | 27M |
| Total Equity | 76.07M | 41.09M | -21.69M | 13.95M | 98.4M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.88M | -2.61M | -883k | -3.64M | -129k |
| Investing | -7.22M | -15.49M | -17.88M | -19.88M | 1.97M |
| Financing | 658k | 814k | 1.14M | 2.1M | 1.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -55.05M | -83.76M | -33.1M | 25.89M | -3.64M |
| Investing | 9.66M | 48.19M | 55.43M | -19.76M | -19.88M |
| Financing | 60.38M | 49.55M | -45.01M | 2.5M | 2.1M |
| Market Cap | 732.25M |
| Price to Earnings Ratio | 60.59 |
| Price to Sales Ratio | 6.92 |
| Price to Cash Ratio | 61.98 |
| Price to Book Ratio | 7.44 |
| Dividend Yield | - |
| Shares Outstanding | 93.76M |
| Average Volume (1 week) | 103.06k |
| Average Volume (1 Month) | 196.42k |
| 52 Week Change | -36.45% |
| 52 Week High | 19.00 |
| 52 Week Low | 6.11 |
| Spread (Intraday) | 0.25 (3.12%) |
| Company Name | Gyre Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.gyretx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
